Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kuipers

Showing results (851-860 of 893) with videos related to

Pageof 90
Sort By:
Annals of Internal Medicine|July 19, 2021
Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy StudyWillemijn de Klaver, Pieter H A Wisse, Francine van Wifferen, et al.
Infection and Immunity|June 1, 1996
Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunityB J Appelmelk, I Simoons-Smit, R Negrini, et al.
The American Journal of Gastroenterology|November 26, 2019
Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening PopulationL J W Bosch, V Melotte, S Mongera, et al.
Endoscopy|September 30, 2015
Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) GuidelineIan M Gralnek, Jean-Marc Dumonceau, Ernst J Kuipers, et al.
Helicobacter|September 1, 2007
Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trialHelena T J I de Leest, Kirsti S S Steen, Willem F Lems, et al.
Gut|May 10, 2022
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic modelReinier G S Meester, Hilliene J van de Schootbrugge-Vandermeer, Emilie C H Breekveldt, et al.
Biomedicines|March 28, 2024
Broad Epitope Coverage of Therapeutic Multi-Antibody Combinations Targeting SARS-CoV-2 Boosts In Vivo Protection and Neutralization Potency to Corner an Immune-Evading VirusIlse Roodink, Maartje van Erp, Andra Li, et al.
Nature Communications|June 8, 2021
HOXA13 in etiology and oncogenic potential of Barrett's esophagusVincent T Janmaat, Kateryna Nesteruk, Manon C W Spaander, et al.
Virchows Archiv : an International Journal of Pathology|December 23, 2011
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)M Dinis-Ribeiro, M Areia, A C de Vries, et al.
Annals of Surgery|January 10, 2022
The Detrimental Impact of the COVID-19 Pandemic on Major Trauma Outcomes in the Netherlands: A Comprehensive Nationwide StudyMitchell L S Driessen, Leontien M Sturms, Frank W Bloemers, et al.
Pageof 90

Showing results (851-860 of 893) with videos related to

Sort By:
Pageof 90
Annals of Internal Medicine|July 19, 2021
Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy StudyWillemijn de Klaver, Pieter H A Wisse, Francine van Wifferen, et al.
Infection and Immunity|June 1, 1996
Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunityB J Appelmelk, I Simoons-Smit, R Negrini, et al.
The American Journal of Gastroenterology|November 26, 2019
Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening PopulationL J W Bosch, V Melotte, S Mongera, et al.
Endoscopy|September 30, 2015
Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) GuidelineIan M Gralnek, Jean-Marc Dumonceau, Ernst J Kuipers, et al.
Helicobacter|September 1, 2007
Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trialHelena T J I de Leest, Kirsti S S Steen, Willem F Lems, et al.
Gut|May 10, 2022
Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic modelReinier G S Meester, Hilliene J van de Schootbrugge-Vandermeer, Emilie C H Breekveldt, et al.
Biomedicines|March 28, 2024
Broad Epitope Coverage of Therapeutic Multi-Antibody Combinations Targeting SARS-CoV-2 Boosts In Vivo Protection and Neutralization Potency to Corner an Immune-Evading VirusIlse Roodink, Maartje van Erp, Andra Li, et al.
Nature Communications|June 8, 2021
HOXA13 in etiology and oncogenic potential of Barrett's esophagusVincent T Janmaat, Kateryna Nesteruk, Manon C W Spaander, et al.
Virchows Archiv : an International Journal of Pathology|December 23, 2011
Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)M Dinis-Ribeiro, M Areia, A C de Vries, et al.
Annals of Surgery|January 10, 2022
The Detrimental Impact of the COVID-19 Pandemic on Major Trauma Outcomes in the Netherlands: A Comprehensive Nationwide StudyMitchell L S Driessen, Leontien M Sturms, Frank W Bloemers, et al.
Pageof 90